Senegal vs Togo: Population requiring preventive chemotherapy for schistosomiasis
Senegal
3.38 million
in 2024
Togo
3.19 million
in 2024
Senegal rank
23rd
Togo rank
25th
Population requiring preventive chemotherapy for schistosomiasis over time
- Senegal
- Togo
How they compare
Senegal currently reports 3.38 million against 3.19 million in Togo, a difference of 187,410.
That makes Senegal's figure about 1.1 times Togo's.
The two have swapped places 4 times across 15 shared years of data; in 2010 it was Senegal ahead.
Senegal ranks 23rd and Togo ranks 25th of 52 countries.
Across the 2 decades both report, Senegal averaged higher in 1 and Togo in 1.
Head to head by decade
| Decade | Senegal | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.81 million | 2.69 million | 1.12 million | Senegal |
| 2020s | 2.93 million | 3.39 million | 461,414 | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Senegal or Togo?
- Senegal, at 3.38 million against 3.19 million in Togo as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Senegal and Togo?
- 187,410, with Senegal ahead.
- How many years of comparable data are there for Senegal and Togo?
- 15 years are reported by both, from 2010 to 2024.
- How do Senegal and Togo rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Senegal ranks 23rd and Togo ranks 25th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.